Direct cardiac effects of a novel vesamicol receptor ligand, m- iodobenzyl-trozamicol, assessed in the canine isolated, blood-perfused heart preparations

Keyphrases

• Action Potential Duration 50%
• Atropine 50%
• Automaticity 50%
• Canine 100%
• Cardiac Effects 100%
• Cardiovascular System 50%
• Cholinergic Function 50%
• Cholinergic Modulation 50%
• Chronotropic Response 50%
• Clinical Application 50%
• Coronary Blood Flow 50%
• Coronary Vasodilators 50%
• Functional Markers 50%
• Inotropic 50%
• Intracoronary Administration 50%
• Ligand-receptor Binding 100%
• Muscarinic Antagonists 50%
• Muscle Preparation 50%
• Papillary muscle 50%
• Perfused Heart 100%
• Repolarization 50%
• Sinoatrial Node 50%
• Sinus Node 50%
• Vasodilator 50%
• Ventricle 50%
• Ventricular Action Potential 50%
• Ventricular Contractility 50%
• Vesamicol 100%

Medicine and Dentistry

• Action Potential 50%
• Action Potential Duration 50%
• Cardiac Imaging 50%
• Cardiovascular System 50%
• Cholinergic Activity 50%
• Chronotropism 50%
• Coronary Circulation 50%
• Coronary Vasodilating Agent 50%
• Heart Ventricle Contraction 50%
• Inotropism 50%
• Intracoronary Drug Administration 50%
• Muscarinic Antagonist 50%
• Papillary Muscle 50%
• Receptor 100%
• Repolarization 50%
• Sinoatrial Node 100%
• Ventricle of Heart 50%
• Vesamicol 100%